Dyne Therapeutics, Inc.

DYN ·Healthcare, Drug Manufacturers - General, United States
Balance Sheet Asset & Liabilities Breakdown

Asset & Liabilities Breakdown

Asset Breakdown FY2025

Total Assets: $1.19B

Liabilities Breakdown FY2025

Total Liabilities: $214.8M